Mutations to both APP and PSEN1/ PSEN2 have been shown to result in mouse models that develop faster and more aggressive amyloidosis than the single APP mutation models as well as earlier cognitive decline and neuronal loss [36]. The gene discussed is APP; the disease is Mental deterioration.